• X-Biotix is a biotechnology company
    specializing in the development of novel small molecule antibiotic
    scaffolds for multi-drug resistant (MDR) Gram-negative pathogens
    to address the urgent and growing global threat of antibiotic
    resistance. The company is applying a multi-target strategy to
    generate a pipeline of effective antibiotics with inhibitory activity
    against a wide range of biological targets in essential pathways of
    Gram-negative bacterial cells and which are also predicted to
    defeat known antibiotic resistance mechanisms.